CAS 385367-47-5
:Tarafenacin
Description:
Tarafenacin, identified by its CAS number 385367-47-5, is a chemical compound that belongs to the class of drugs known as anticholinergics. It is primarily investigated for its potential use in treating conditions such as overactive bladder and other urinary disorders. The compound exhibits properties that allow it to inhibit the action of acetylcholine at muscarinic receptors, leading to a reduction in involuntary bladder contractions. Tarafenacin is characterized by its selective binding affinity, which aims to minimize side effects commonly associated with anticholinergic medications. Its pharmacokinetic profile typically includes oral bioavailability, metabolism primarily through hepatic pathways, and renal excretion of metabolites. As with many pharmaceuticals, the safety and efficacy of Tarafenacin are evaluated through clinical trials, focusing on its therapeutic benefits and potential adverse effects. Overall, Tarafenacin represents a targeted approach in the management of urinary conditions, contributing to the broader category of anticholinergic therapies.
Formula:C21H20F4N2O2
InChI:InChI=1S/C21H20F4N2O2/c22-15-2-1-3-16(10-15)27(11-13-8-17(23)20(25)18(24)9-13)21(28)29-19-12-26-6-4-14(19)5-7-26/h1-3,8-10,14,19H,4-7,11-12H2/t19-/m0/s1
InChI key:InChIKey=UXZDMXYRRQJIBJ-IBGZPJMESA-N
SMILES:O(C(N(CC1=CC(F)=C(F)C(F)=C1)C2=CC(F)=CC=C2)=O)[C@@H]3C4CCN(C3)CC4
Synonyms:- (R)-Quinuclidin-3-yl (3-fluorophenyl)(3,4,5-trifluorobenzyl)carbamate
- Carbamic acid, N-(3-fluorophenyl)-N-[(3,4,5-trifluorophenyl)methyl]-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester
- Tarafenacin
- Carbamic acid, (3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
Tarafenacin
CAS:<p>Tarafenacin is a highly selective M3 muscarinic receptor antagonist (Ki= 0.19 nM), ~200 fold selectivity over the M2 receptor.</p>Formula:C21H20F4N2O2Purity:98%Color and Shape:SolidMolecular weight:408.39
